Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tim A Fischell

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
Blood Pressure|May 16, 2022
Impact of drug adherence on blood pressure response to alcohol-mediated renal denervationAlexandre Persu, Frédéric Maes, Stefan W Toennes, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 21, 2013
Ethanol-mediated perivascular renal sympathetic denervation: preclinical validation of safety and efficacy in a porcine modelTim A Fischell, Felix Vega, Narayan Raju, et al.
American Heart Journal|May 30, 2021
Catheter-based alcohol-mediated renal denervation for the treatment of uncontrolled hypertension: design of two sham-controlled, randomized, blinded trials in the absence (TARGET BP OFF-MED) and presence (TARGET BP I) of antihypertensive medicationsFelix Mahfoud, Michael Weber, Roland E Schmieder, et al.
Journal of the American College of Cardiology|September 25, 2010
Initial clinical results using intracardiac electrogram monitoring to detect and alert patients during coronary plaque rupture and ischemiaTim A Fischell, David R Fischell, Alvaro Avezum, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|September 2, 2021
Blood pressure lowering with alcohol-mediated renal denervation using the Peregrine infusion Catheter is independent of injection site locationFelix Mahfoud, Stefan Bertog, Lucas Lauder, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|September 22, 2020
Alcohol-Mediated Renal Sympathetic Neurolysis for the Treatment of Hypertension: The Peregrine™ Infusion CatheterStefan Bertog, Alok Sharma, Felix Mahfoud, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|July 10, 2023
Alcohol-mediated renal denervation in patients with hypertension in the absence of antihypertensive medicationsAtul Pathak, Ulrike M Rudolph, Manish Saxena, et al.
Circulation. Cardiovascular Interventions|September 2, 2021
Long-Term Results up to 12 Months After Catheter-Based Alcohol-Mediated Renal Denervation for Treatment of Resistant HypertensionFelix Mahfoud, Horst Sievert, Stefan Bertog, et al.
Circulation|April 8, 2024
Effect of Alcohol-Mediated Renal Denervation on Blood Pressure in the Presence of Antihypertensive Medications: Primary Results From the TARGET BP I Randomized Clinical TrialDavid E Kandzari, Michael A Weber, Atul Pathak, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|September 27, 2007
The SIRIUS-DIRECT trial: a multi-center study of direct stenting using the sirolimus-eluting stent in patients with de novo native coronary artery lesionsJeffrey W Moses, Giora Weisz, Gregory Mishkel, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Blood Pressure|May 16, 2022
Impact of drug adherence on blood pressure response to alcohol-mediated renal denervationAlexandre Persu, Frédéric Maes, Stefan W Toennes, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 21, 2013
Ethanol-mediated perivascular renal sympathetic denervation: preclinical validation of safety and efficacy in a porcine modelTim A Fischell, Felix Vega, Narayan Raju, et al.
American Heart Journal|May 30, 2021
Catheter-based alcohol-mediated renal denervation for the treatment of uncontrolled hypertension: design of two sham-controlled, randomized, blinded trials in the absence (TARGET BP OFF-MED) and presence (TARGET BP I) of antihypertensive medicationsFelix Mahfoud, Michael Weber, Roland E Schmieder, et al.
Journal of the American College of Cardiology|September 25, 2010
Initial clinical results using intracardiac electrogram monitoring to detect and alert patients during coronary plaque rupture and ischemiaTim A Fischell, David R Fischell, Alvaro Avezum, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|September 2, 2021
Blood pressure lowering with alcohol-mediated renal denervation using the Peregrine infusion Catheter is independent of injection site locationFelix Mahfoud, Stefan Bertog, Lucas Lauder, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|September 22, 2020
Alcohol-Mediated Renal Sympathetic Neurolysis for the Treatment of Hypertension: The Peregrine™ Infusion CatheterStefan Bertog, Alok Sharma, Felix Mahfoud, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|July 10, 2023
Alcohol-mediated renal denervation in patients with hypertension in the absence of antihypertensive medicationsAtul Pathak, Ulrike M Rudolph, Manish Saxena, et al.
Circulation. Cardiovascular Interventions|September 2, 2021
Long-Term Results up to 12 Months After Catheter-Based Alcohol-Mediated Renal Denervation for Treatment of Resistant HypertensionFelix Mahfoud, Horst Sievert, Stefan Bertog, et al.
Circulation|April 8, 2024
Effect of Alcohol-Mediated Renal Denervation on Blood Pressure in the Presence of Antihypertensive Medications: Primary Results From the TARGET BP I Randomized Clinical TrialDavid E Kandzari, Michael A Weber, Atul Pathak, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|September 27, 2007
The SIRIUS-DIRECT trial: a multi-center study of direct stenting using the sirolimus-eluting stent in patients with de novo native coronary artery lesionsJeffrey W Moses, Giora Weisz, Gregory Mishkel, et al.
Pageof 7